Healthcare Triangle, Inc. (HCTI) — SEC Filings
Healthcare Triangle, Inc. (HCTI) — 50 SEC filings. Latest: 8-K (Dec 10, 2025). Includes 29 8-K, 6 10-Q, 4 S-1/A.
View Healthcare Triangle, Inc. on SEC EDGAR
Overview
Healthcare Triangle, Inc. (HCTI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 10, 2025: On December 5, 2025, Healthcare Triangle, Inc. entered into a material definitive agreement. The company also provided a Regulation FD disclosure and filed financial statements and exhibits as part of this 8-K filing.
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 11 bearish, 37 neutral, 2 mixed. The dominant filing sentiment for Healthcare Triangle, Inc. is neutral.
Filing Type Overview
Healthcare Triangle, Inc. (HCTI) has filed 29 8-K, 3 DEF 14A, 6 10-Q, 3 8-K/A, 4 S-1/A, 1 S-1, 2 10-K, 2 10-K/A with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of HCTI's 44 recent filings, 11 were flagged as high-risk, 21 as medium-risk, and 12 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $10.75M |
| Net Income | -$4.97M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $1.63M |
| Operating Margin | N/A |
| Total Assets | $13.84M |
| Total Debt | $1.53M |
Key Executives
- David Ayanoglou
- Dave Rosa
- Sujatha Ramesh
- Ronald McClurg
- Jainal Bhuiyan
- Pleasanton, CA
- Ross Carmel
- Jeffrey Wofford
- Thyagarajan Ramachandran
- Robert J. W. Smith
- Dr. David J. Smith
- Mr. David L. Smith
- Brian Margolis
Industry Context
Healthcare Triangle, Inc. operates within the healthcare technology sector, which is characterized by rapid innovation, evolving regulatory landscapes, and significant capital requirements for research, development, and market penetration. Companies in this space often rely on external funding to fuel growth and navigate competitive pressures. The need for capital to support ongoing operations suggests potential challenges in generating sufficient internal cash flow.
Top Tags
material-agreement (10) · delisting (8) · financial-obligation (5) · amendment (5) · equity-sale (4) · corporate-governance (4) · regulatory-filing (4) · listing-standards (4) · compliance (4) · 10-Q (4)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Aggregate Future Issuances | $70M | Maximum capital to be raised through security issuances |
| Max Common Shares Issuable | 50,000,000 | Potential dilution from common stock issuance |
| Max Warrant Shares Issuable | 100,000,000 | Potential dilution from warrant exercise |
| Max Discount to Market | 80% | Significant potential discount for future security sales |
| Common Stock Outstanding | 7,261,344 | Shares outstanding as of November 12, 2025 record date |
| Series A Super Voting Preferred Stock Outstanding | 20,000 | Shares outstanding with 1,000 votes per share |
| Special Meeting Time | 10:00 a.m. PT | Time of the virtual stockholder meeting on November 28, 2025 |
| Record Date | November 12, 2025 | Date for determining stockholders entitled to vote |
| Issuance Deadline | February 28, 2026 | Latest date for completing approved future issuances |
| Votes per Series A Preferred Share | 1,000 | Voting power of Series A Super Voting Preferred Stock |
| Net Revenue | $10.75M | Increased from $9.51M for the nine months ended September 30, 2024 |
| Net Loss | $4.97M | Increased from $4.62M for the nine months ended September 30, 2024 |
| Cash and Cash Equivalents | $1.63M | Increased from $20K at December 31, 2024 |
| Net Proceeds from Equity Issuance | $14.31M | Primary source of cash for the nine months ended September 30, 2025 |
| Accumulated Deficit | $38.52M | Increased from $33.57M at December 31, 2024 |
Forward-Looking Statements
- {"claim":"Healthcare Triangle, Inc. will proceed with a public offering of securities.","entity":"Healthcare Triangle, Inc.","targetDate":"Q2 2024","confidence":"medium"}
- {"claim":"Healthcare Triangle, Inc. will proceed with a public offering of securities.","entity":"Healthcare Triangle, Inc.","targetDate":"As soon as practicable after this Registration Statement becomes effective.","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Healthcare Triangle, Inc. (HCTI)?
Healthcare Triangle, Inc. has 50 recent SEC filings from Jan 2024 to Dec 2025, including 29 8-K, 6 10-Q, 4 S-1/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of HCTI filings?
Across 50 filings, the sentiment breakdown is: 11 bearish, 37 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Healthcare Triangle, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Healthcare Triangle, Inc. (HCTI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Healthcare Triangle, Inc.?
Key financial highlights from Healthcare Triangle, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for HCTI?
The investment thesis for HCTI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Healthcare Triangle, Inc.?
Key executives identified across Healthcare Triangle, Inc.'s filings include David Ayanoglou, Dave Rosa, Sujatha Ramesh, Ronald McClurg, Jainal Bhuiyan and 8 others.
What are the main risk factors for Healthcare Triangle, Inc. stock?
Of HCTI's 44 assessed filings, 11 were flagged high-risk, 21 medium-risk, and 12 low-risk.
What are recent predictions and forward guidance from Healthcare Triangle, Inc.?
Recent forward-looking statements from Healthcare Triangle, Inc. include guidance on {"claim":"Healthcare Triangle, Inc. will proceed with a public offering of securities.","entity":"Healthcare Triangle, I and 1 other predictions.